Your search history is turned on.
Date: May 9, 2024 06:07:26 EST Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Microsoft Word - a53980880-release.htm Aurinia Presents Data Reinforcing LUPKYNIS Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024 A propensity analysis of ALMS, AURA-LV, and AURORA 1 suggested that initial therapy with LUPKYNIS plus standard of care reduced exposure to potential toxicities and demonstrated earlie...
Date: May 7, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Microsoft Word - a53976025-release Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--May 7, 2024--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 RBC Capital Markets Global Healthcare Conference in New York from May 14- 15, 2...
Date: May 3, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
2024 DEFA14A U.S. Notice and Access Card May 3 2024-2024-05-03-15-27 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 __________________________________________________ Filed by the Regi...
Form of Proxy - Annual General Meeting to be held on Friday, June 14, 2024 01ZS8D This Form of Proxy is solicited by and on behalf of Management and the Board of Directors. Fold Fold CONTROL NUMBER To vote by telephone or the Internet, you will need to provide your CONTROL NUMBER listed below. If you vote by telephone or the Internet, DO NOT mail back this prox...
Aurinia Pharmaceuticals Inc. 2024 Definitive Proxy UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 __________________________________________________ Filed by the Registrant ...
ExtractPage3 ...
Date: May 2, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Q1 2024 10-Q-2024-05-01-20-41 Exhibit 31.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Joseph Miller, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Aurinia Pharmaceuticals Inc..; 2. Based on my knowledge, this report doe...
Q1 2024 10-Q-2024-05-01-20-41 Exhibit 31.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO EXCHANGE RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Peter Greenleaf, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Aurinia Pharmaceuticals Inc.; 2. Based on my knowledge, this...
Q1 2024 10-Q-2024-05-01-20-41 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _____________________________________________ FORM 10-Q _____________________________________________ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR TRANSITION R...